The president and chief executive of MannKind has stepped down, Seeking Alpha reports, and founder Alfred Mann has stepped in temporarily. Sales of the Valencia company’s inhalable insulin are going badly, and a quick stock sale in Israel to raise emergency cash was a big disappointment. “MannKind’s remaining options are shrinking fast,” reports Motley Fool.